QAL
Asset Logo

Qualitas Limited

🇦🇺 ASX

💸 FINANCIALS

Compare
Add to watchlist
👑 Overview

📈 Performance

💰 Dividends

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

+ 1.99%
Annual Growth

3 years average annual growth

💰

3.48%
Annual dividend yield

Based on the most recent dividend

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Qualitas Ltd. engages in real estate management services. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-12-16. The firm offers a range of investment solutions for institutional, wholesale and retail clients. The company offers flexible capital solutions for its partners, creating long term value for shareholders and the communities in which it operates. The firm is focused on real estate private credit, opportunistic real estate private equity, income-producing commercial real estate and build-to-rent residential. The firm has two segments: Funds Management and Direct Lending. The Funds Management segment includes all the Company’s core funds management activities and includes funds management fees, performance fees and other fee income. The company also includes dividends and distributions from its co-investment and direct lending activities. The Direct Lending segment relates to the interest income and expenses relating to activities undertaken by its wholly owned subsidiaries Arch Finance and Peer Estate.

📈 Performance

Price History

+6.00%

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💰 Dividends

Payouts

💰 Annual Dividend Yield*

3.48%

💰 Annual Dividend Earnings Per $1,000 invested**

$34.78

💰 Most Recent Dividend Franked Percentage Estimate

100.00%

💰 Average Dividend Franked Percentage Estimate

100.00 %

💰 Dividend reinvestment

Learn more

* Based on the most recent dividend

** Calculated by multiplying the most recent dividend yield by $1,000

Estimate your dividend

If you held

$

of QAL, your last dividend payment(s) would have been:

$ 349.54

on Thu Oct 03 2024

$ 121.29

on Thu Mar 28 2024

*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.

Dividend History

1Y

5Y

10Y

Graph

Table

Year
Yearly Dividend Earnings Per Share
Franking Estimate

2024

$0.08

100.00%

2023

$0.07

100.00%

2022

$0.04

100.00%

2021

$0.00

0.00%

2020

$0.00

0.00%

2019

$0.00

0.00%

2018

$0.00

0.00%

2017

$0.00

0.00%

2016

$0.00

0.00%

2015

$0.00

0.00%

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$2.65

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in QAL

1

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

42 weeks

💵 Average investment amount

$168

Last time a customer invested in QAL

1073 days
QAL investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

100%

Less than 50k

👶 Age of investors

18 - 25

26 - 34

100%

35 - 90

🙋 Legal gender of investors

Female

Male

100%

Pearlers who invest in QAL also invest in...

Vanguard Australian Shares Index ETF

VAS

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

🙌 Performance (5Yr p.a)

3.39%

📊 Share price

$101.11 AUD

🇦🇺 AUSTRALIA

⛳️ DIVERSIFIED

🧱 MATERIALS

💸 FINANCIALS

Find Out More

Qantas Airways Ltd. engages in international and domestic air transportation services. The company is headquartered in Mascot, New South Wales. The principal activities of the Company include the operation of international and domestic air transportation services and provision of freight services and the operation of a frequent flyer loyalty program. The Company’s segments include Qantas Domestic, Qantas International, Jetstar Group, Qantas Loyalty, and Corporate. Qantas Domestic is a carrier in the Australian domestic market measured by capacity. Qantas Domestic offers on-board Wi-Fi and upgrades to the domestic lounges. Qantas International is a carrier into and out of Australia, also targeting business and premium leisure customers who value the full-service experience. Jetstar Group has domestic and international routes in Australia, joint ventures in Singapore and Japan. Qantas Loyalty is comprised of consumer and SME coalition loyalty programs. Its airline brands operate regional, domestic, and international services.

🙌 Performance (5Yr p.a)

3.87%

📊 Share price

$8.82 AUD

✈️ AIRLINES

IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

🙌 Performance (5Yr p.a)

20.53%

📊 Share price

$63.52 AUD

📈 HIGH PRICE GROWTH

🇺🇸 UNITED STATES

ASIA.AX was created on 2018-09-18 by BetaShares. The fund's investment portfolio concentrates primarily on information technology equity. The investment objective of the BetaShares Asia Technology Tigers ETF is to provide an investment return that aims to track the performance of the Solactive Asia ex-Japan Technology & Internet Tigers Index (the Index), before taking into account fees and expenses.

🙌 Performance (5Yr p.a)

8.11%

📊 Share price

$10.19 AUD

📈 HIGH PRICE GROWTH

🇦🇺 EX AUSTRALIA

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

🙌 Performance (5Yr p.a)

3.75%

📊 Share price

$7.85 AUD

🩺 HEALTH CARE

🌏 GLOBAL

Want more shares? Try these...

Qantas Airways Ltd. engages in international and domestic air transportation services. The company is headquartered in Mascot, New South Wales. The principal activities of the Company include the operation of international and domestic air transportation services and provision of freight services and the operation of a frequent flyer loyalty program. The Company’s segments include Qantas Domestic, Qantas International, Jetstar Group, Qantas Loyalty, and Corporate. Qantas Domestic is a carrier in the Australian domestic market measured by capacity. Qantas Domestic offers on-board Wi-Fi and upgrades to the domestic lounges. Qantas International is a carrier into and out of Australia, also targeting business and premium leisure customers who value the full-service experience. Jetstar Group has domestic and international routes in Australia, joint ventures in Singapore and Japan. Qantas Loyalty is comprised of consumer and SME coalition loyalty programs. Its airline brands operate regional, domestic, and international services.

🙌 Performance (5Yr p.a)

3.87%

📊 Share price

$8.82 AUD

✈️ AIRLINES

QAU.AX was created on 2011-05-03 by BetaShares. The fund's investment portfolio concentrates primarily on gold commodities. The investment objective of the Fund is to provide an investment return, before fees and expenses, that closely tracks the performance of the price of gold bullion, with a currency hedge against movements in the AUD/USD exchange rate.

🙌 Performance (5Yr p.a)

8.82%

📊 Share price

$21.44 AUD

📞 COMMUNICATIONS

📈 HIGH PRICE GROWTH

PolarX Ltd. is a mineral exploration and development company, which focuses on gold, silver, and copper exploration and its development. The company is headquartered in Subiaco, Western Australia and currently employs 1 full-time employees. The company went IPO on 2012-12-21. The firm is focused on copper, gold, and silver projects in United States of America. Its projects include Caribou Dome Copper project, Stellar Copper-Gold project, Humboldt Range Gold-Silver project, and Fourth of July project. The Caribou Dome Copper project comprises approximately 216 contiguous state mining claims and is located adjacent to the Company’s Stellar project. The claims cover a total area of 116 square kilometers (km2). The Stellar Copper-Gold project comprises approximately 231 contiguous State Mining Claims and is located immediately adjacent to the Company’s Caribou Dome Copper Project. The claims cover a total area of 150 Km2. The Humboldt Range Gold-Silver project comprises 364 lode mining claims in Nevada in two claim groups: Black Canyon and Fourth of July and is situated between two large-scale active mines: the Florida Canyon gold mine and the Rochester silver-gold mine.

🙌 Performance (5Yr p.a)

-17.20%

📊 Share price

$0.01 AUD

⛏️ MINING

PYC Therapeutics Ltd is a AU-based company operating in Biotechnology industry. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2005-03-30. PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company creating a new generation of ribonucleic acid (RNA) therapies to change the lives of patients with genetic diseases. The firm utilizes its proprietary drug delivery platform to enhance the potency of precision medicines within the rapidly growing and commercially proven RNA therapeutic class. Its drug development programs target monogenic diseases - the indications with the highest likelihood of success in clinical development. Its first-in-class drug programs include Retinitis Pigmentosa type 11, (VP-001), Polycystic Kidney Disease, (PYC-003), Autosomal Dominant Optic Atrophy (ADOA) (PYC-001) and Phelan-McDermid Syndrome (PMS) (PYC-002). The firm's VP-001 program is a lead asset for a blinding eye disease of childhood progressed through multiple patient cohorts in the ongoing single ascending dose clinical trial. ADOA is a progressive and blinding eye disease.

🙌 Performance (5Yr p.a)

483.73%

📊 Share price

$1.45 AUD

🧬 BIOTECHNOLOGY

Compare
Add to watchlist